As of 2025-09-18, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (313.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -130127.5%.
The range of the Relative Valuation is (320.54) - (316.84) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 14.1x | 14.0x |
| Forward P/E multiples | 12.6x - 13.7x | 13.2x |
| Fair Price | (320.54) - (316.84) | (313.50) |
| Upside | -133048.9% - -131516.3% | -130127.5% |
| Date | P/E |